The Artificial Intelligence (AI) Market in Respiratory Diseases is Set to Experience Steady Growth at a 5% CAGR - The National Law Review

AI technology being used to diagnose and treat respiratory diseases is expected to grow steadily in the coming years. This could eventually improve healthcare for people with conditions like asthma and COPD, though growth is modest.